The relationship between hallucinations and FDG-PET in dementia with Lewy bodies

Brain Imaging and Behavior

Volumn 10, Issue 3, 2016, Pages 636-639

  Firbank, Michael J ^a   Lloyd, Jim ^b   O’Brien, John T ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

DLB; FDG; Occipital lobe; Visual hallucinations

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AUDITORY HALLUCINATION; BRAIN METABOLISM; CEREBELLUM; CLINICAL ARTICLE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HALLUCINATION; HUMAN; MALE; NEUROPSYCHIATRIC INDEX; NEUROPSYCHIATRIC INDEX HALLUCINATION SCORE; NEUROPSYCHOLOGICAL TEST; OCCIPITAL LOBE; PRIORITY JOURNAL; SCORING SYSTEM; TACTILE HALLUCINATION; VISUAL HALLUCINATION; BRAIN; BRAIN MAPPING; COMPLICATION; DIAGNOSTIC IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VISUAL SYSTEM; X-RAY COMPUTED TOMOGRAPHY;

AGED; BRAIN; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; VISUAL PATHWAYS;

EID: 84938631553     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-015-9434-0     Document Type: Article

References (16)

1. Colloby, S. J., Fenwick, J. D., Williams, E. D., Paling, S. M., Lobotesis, K., Ballard, C., et al. (2002). A comparison of Tc-99 m-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29(5), 615–622. doi:10.1007/s00259-002-0778-5.
2. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314.
3. Imamura, T., Ishii, K., Hirono, N., Hashimoto, M., Tanimukai, S., Kazuai, H., et al. (1999). Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport, 10(9), 1903–1907.
4. Ishii, K., Yamaji, S., Kitagaki, H., Imamura, T., Hirono, N., & Mori, E. (1999). Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology, 53(2), 413–416.
5. Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C., et al. (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56(5), 643–649.
6. McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65(12), 1863–1872. doi:10.1212/01.wnl.0000187889.17253.b1.
7. Mori, T., Ikeda, M., Fukuhara, R., Nestor, P. J., & Tanabe, H. (2006). Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology, 66, 935–937.
8. Mukaetova-Ladinska, E. B., Andras, A., Milne, J., Abdel-All, Z., Bohr, I., Jaros, E., et al. (2013). Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology, 72(1), 53–60. doi:10.1097/NEN.0b013e31827c5710.
9. O’Brien, J. T., Firbank, M. J., Davison, C., Barnett, N., Bamford, C., Donaldson, C., et al. (2014). FDG-PET and perfusion SPECT in the diagnosis of Alzheimer’s disease and Lewy body dementias. Journal of Nuclear Medicine, 55(12), 1959–1965. doi:10.2967/jnumed.114.143347.
10. Okamura, N., Arai, H., Higuchi, M., Tashiro, M., Matsui, T., Hu, X.-S., et al. (2001). [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer’s disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25(2), 447–456. doi:10.1016/S0278-5846(01)80005-1.
11. Onofrj, M., Taylor, J. P., Monaco, D., Franciotti, R., Anzellotti, F., Bonanni, L., et al. (2013). Visual hallucinations in PD and Lewy body dementias: old and new hypotheses. Behavioural Neurology, 27(4), 479–481. doi:10.3233/BEN-129022.
12. Pasquier, J., Michel, B. F., Brenot-Rossi, I., Hassan-Sebbag, N., Sauvan, R., & Gastaut, J. L. (2002). Value of Tc99m-ECD SPET for the diagnosis of dementia with lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging, 29(10), 1342–1348.
13. Perneczky, R., Drzezga, A., Boecker, H., Forstl, H., Kurz, A., & Haussermann, P. (2008). Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dementia and Geriatric Cognitive Disorders, 25(6), 531–538. doi:10.1159/000132084.
14. Riedl, V., Bienkowska, K., Strobel, C., Tahmasian, M., Grimmer, T., Förster, S., et al. (2014). Local activity determines functional connectivity in the resting human brain: a simultaneous FDG-PET/fMRI study. The Journal of Neuroscience, 34(18), 6260–6266. doi:10.1523/JNEUROSCI.0492-14.2014.
15. Satoh, M., Ishikawa, H., Meguro, K., Kasuya, M., Ishii, H., & Yamaguchi, S. (2010). Improved visual hallucination by Donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project. European Neurology, 64(6), 337–344. doi:10.1159/000322121.
16. Taylor, J. P., Firbank, M. J., He, J., Barnett, N., Pearce, S., Livingstone, A., et al. (2012). Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. British Journal of Psychiatry, 200(6), 491–498. doi:10.1192/bjp.bp.111.099432.